Literature DB >> 4066269

Discrimination between senile dementia Alzheimer type patients and -education matched normal controls by means of a 6-test set.

R Bandera, E Capitani, S Della Sala, H Spinnler.   

Abstract

Discrimination between senile dementia Alzheimer type (SDAT) patients (N = 30) and Normal Controls (N = 60) by means of a 6-test set was assessed. Performances on Word Fluency (FL), Memory for Prose (PM) and Finger Agnosia (FA) nearly exhaust the discriminant power of the whole battery, including Constructional Apraxia (CA), Token Test (TT) and Weigl's Sorting Test (WT). The battery, however, leaves some facets of the difference between SDAT patients and Controls unexplored, misclassifying almost 20% of the SDAT patients and 10% of the Controls. We emphasize the role of discriminant analysis in the evaluation of any neuropsychological battery of tests which has to be used for diagnostic purposes.

Entities:  

Mesh:

Year:  1985        PMID: 4066269     DOI: 10.1007/BF02232012

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  9 in total

1.  The token test: A sensitive test to detect receptive disturbances in aphasics.

Authors:  E DE RENZI; L A VIGNOLO
Journal:  Brain       Date:  1962-12       Impact factor: 13.501

2.  Alzheimer's disease: its natural history and differential diagnosis.

Authors:  M SIM; I SUSSMAN
Journal:  J Nerv Ment Dis       Date:  1962-12       Impact factor: 2.254

3.  Morbus Alzheimer and morbus Pick; a genetic, clinical and patho-anatomical study.

Authors:  T SJOGREN; H SJOGREN; A G LINDGREN
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1952

4.  Normative data and screening power of a shortened version of the Token Test.

Authors:  E De Renzi; P Faglioni
Journal:  Cortex       Date:  1978-03       Impact factor: 4.027

5.  The assessment and analysis of handedness: the Edinburgh inventory.

Authors:  R C Oldfield
Journal:  Neuropsychologia       Date:  1971-03       Impact factor: 3.139

6.  Perceptual and associative disorders of visual recognition. Relationship to the side of the cerebral lesion.

Authors:  E De Renzi; G Scotti; H Spinnler
Journal:  Neurology       Date:  1969-07       Impact factor: 9.910

7.  Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome.

Authors:  H A Crystal; D S Horoupian; R Katzman; S Jotkowitz
Journal:  Ann Neurol       Date:  1982-08       Impact factor: 10.422

8.  Visuospatial judgment. A clinical test.

Authors:  A L Benton; N R Varney; K D Hamsher
Journal:  Arch Neurol       Date:  1978-06

9.  Language disturbance. An initial symptom of cortical degenerations and dementia.

Authors:  H S Kirshner; W G Webb; M P Kelly; C E Wells
Journal:  Arch Neurol       Date:  1984-05
  9 in total
  5 in total

Review 1.  The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Karin Lind; Åke Edman; Mattias Göthlin; Jacob Stålhammar; Marie Eckerström; Silke Kern; Anne Börjesson-Hanson; Mårten Carlsson; Erik Olsson; Henrik Zetterberg; Kaj Blennow; Johan Svensson; Annika Öhrfelt; Maria Bjerke; Sindre Rolstad; Carl Eckerström
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Ideomotor apraxia in patients with dementia of Alzheimer type.

Authors:  S Della Sala; F Lucchelli; H Spinnler
Journal:  J Neurol       Date:  1987-02       Impact factor: 4.849

3.  The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition.

Authors:  A Nordlund; S Rolstad; P Hellström; M Sjögren; S Hansen; A Wallin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

Review 4.  The role of clinical neuropsychology in the neurological diagnosis of Alzheimer's disease.

Authors:  H Spinnler; S Della Sala
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

5.  Better prognostic accuracy in younger mild cognitive impairment patients with more years of education.

Authors:  Mattias Göthlin; Marie Eckerström; Sindre Rolstad; Petronella Kettunen; Anders Wallin
Journal:  Alzheimers Dement (Amst)       Date:  2018-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.